Abstract:The E3 ubiquitin ligase MDM2 functions as a crucial negative regulator of the p53 tumor suppressor protein by antagonizing p53 transactivation activity and targeting p53 for degradation. Cellular stress activates p53 by alleviating MDM2-mediated functional inhibition, even though the molecular mechanisms of stress-induced p53 activation still remain poorly understood. Two opposing models have been proposed to describe the functional and structural role in p53 activation of Ser17 phosphorylation in the N-terminal "lid" (residues 1-24) of MDM2. Using the native chemical ligation technique, we synthesized the p53-binding domain (1-109)MDM2 and its Ser17-phosphorylated analogue (1-109)MDM2 pS17 as well as (1-109)MDM2 S17D and (25-109)MDM2, and comparatively characterized their interactions with a panel of p53-derived peptide ligands using surface plasmon resonance, fluorescence polarization, and NMR and CD spectroscopic techniques. We found that the lid is partially structured in apo-MDM2 and occludes p53 peptide binding in a ligand size-dependent manner. Binding of (1-109)MDM2 by the (15-29)p53 peptide fully displaces the lid and renders it completely disordered in the peptide-protein complex. Importantly, neither Ser17 phosphorylation nor the phospho-mimetic mutation S17D has any functional impact on p53 peptide binding to MDM2. Although Ser17 phosphorylation or its mutation to Asp contributes marginally to the stability of the lid conformation in apo-MDM2, neither modification stabilizes apo-MDM2 globally or the displaced lid locally. Our findings demonstrate that Ser17 phosphorylation is functionally neutral with respect to p53 binding, suggesting that MDM2 phosphorylation at a single site is unlikely to play a dominant role in stress-induced p53 activation.

The MDM2-binding Region in the Transactivation Domain of P53 Also Acts As a Bcl-X(L)-binding Motif.

Negative Regulation of p53 Functions by Daxx and the Involvement of MDM2

The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl.

A Conserved Mechanism for Binding of p53 DNA-Binding Domain and Anti-Apoptotic Bcl-2 Family Proteins

Inhibition of Nonsense-Mediated Decay Rescues P53β/γ Isoform Expression and Activates the P53 Pathway in MDM2-overexpressing and Select P53-Mutant Cancers

Bcl2'S Flexible Loop Domain Regulates P53 Binding and Survival

Anti-apoptosis Proteins Mcl-1 and Bcl-xL Have Different P53-Binding Profiles.

Secondary Interaction Between MDMX and P53 Core Domain Inhibits P53 DNA Binding.

Modulation of the p53-MDM2 Interaction by Phosphorylation of Thr18: A Computational Study

Functional Interrogation of the N-Terminal Lid of MDMX in p53 Binding via Native Chemical Ligation.

Interaction Between P53 N Terminus and Core Domain Regulates Specific and Nonspecific DNA Binding.

Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity

Interrogation of MDM2 Phosphorylation in P53 Activation Using Native Chemical Ligation: the Functional Role of Ser17 Phosphorylation in MDM2 Reexamined

Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2

Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein.

A Conserved Hydrophobic Core At Bcl-X(L) Mediates Its Structural Stability And Binding Affinity With Bh3-Domain Peptide Of Pro-Apoptotic Protein

Mdm-2 binding and TAFII31 recruitment is regulated by hydrogen bond disruption between the p53 residues Thr18 and Asp21

Structure of Human Mdm2 Complexed with Rpl11 Reveals the Molecular Basis of P53 Activation

B1-induced Caspase-Independent Apoptosis in MCF-7 Cells is Mediated by Down-Regulation of Bcl-2 Via P53 Binding to P2 Promoter TATA Box

Structural adaptation of secondary p53 binding sites on MDM2 and MDMX

P53 and Bad： Remote Strangers Become Close Friends